Literature DB >> 4240215

Sebum changes in acne vulgaris treated with tetracycline.

G W Beveridge, E W Powell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4240215     DOI: 10.1111/j.1365-2133.1969.tb16027.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  7 in total

1.  [Skin surface lipids: qualitative and quantitative determination in patients with acne vulgaris and controls. I].

Authors:  M Gloor; U Graumann; M Kionke; I Wiegand; H C Friederich
Journal:  Arch Dermatol Forsch       Date:  1972

2.  [Influence of tetracycline therapy in acne vulgaris on the quantity and composition of skin surface lipids at varying dosage. I].

Authors:  M Gloor; U Graumann; I Wiegand; H C Friederich
Journal:  Arch Dermatol Forsch       Date:  1972

3.  [Electrophoretical and immunologic investigations of ester-splitting enzymes in human skin].

Authors:  W P Herrmann
Journal:  Arch Klin Exp Dermatol       Date:  1970

4.  [Demonstration and origin of the nonspecific carboxylesterase with gamma-mobility (gamma-organ esterase) on the human skin surface].

Authors:  W P Herrmann; M Heinen; K Jung
Journal:  Arch Klin Exp Dermatol       Date:  1970

5.  Further observations on the pathogenesis of acne.

Authors:  J A Cotterill; W J Cunliffe; B Williamson; L Bulusu
Journal:  Br Med J       Date:  1972-08-19

6.  Tetracycline and acne vulgaris: a clinical and laboratory investigation.

Authors:  W J Cunliffe; R A Forster; N D Greenwood; C Hetherington; K T Holland; R L Holmes; S Khan; C D Roberts; M Williams; B Williamson
Journal:  Br Med J       Date:  1973-11-10

7.  Are therapeutic effects of antiacne agents mediated by activation of FoxO1 and inhibition of mTORC1?

Authors:  Bodo C Melnik; Gerd Schmitz
Journal:  Exp Dermatol       Date:  2013-07       Impact factor: 3.960

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.